Subscribe Sign In Register

Premium

Hedge Fund Titans Bet Big on Drugmaker Shire’s Success

John Paulson, Dan Loeb, and other prominent Investors move into an industry in flux.

By Bailey McCann
December 8, 2016
2016-autumn-bailey-mccann-inside-the-trade-medical-article-page.jpg
Illustration by Renaud Vigor.

For the past few years, Shire has been defined by two things: popular niche drugs and failed M&A.

To continue reading, subscribe now to Premium Journalism. Already a subscriber? login.

Lone Pine Capital Shire John Paulson Dan Loeb Suvretta Capital Management Marshall Wace Hedge Fund
Related
Art_RAcapital_0423.jpg
Hedge Funds
RA Capital’s Buying Spree
Stephen Taub
April 23, 2024
discoverycapital_0422.jpg
Hedge Funds
Discovery Is Off to a Strong Start
Stephen Taub
April 22, 2024
Gold in Turbulent Times
Sponsored
The Role of Gold in Turbulent Times